Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administrat (Q47832682)
Jump to navigation
Jump to search
scientific article published in July 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administrat |
scientific article published in July 1998 |
Statements
1 reference
Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administrat (English)
1 reference
J M Tourani
1 reference
C Pfister
1 reference
J F Berdah
1 reference
A Benhammouda
1 reference
P Salze
1 reference
A Monnier
1 reference
B Paule
1 reference
P Guillet
1 reference
Y Chretien
1 reference
Y Brewer
1 reference
M Di Palma
1 reference
M Untereiner
1 reference
E Malaurie
1 reference
Z Tadrist
1 reference
J M Pavlovitch
1 reference
D Hauteville
1 reference
A Mejean
1 reference
M Azagury
1 reference
D Mayeur
1 reference
V Lucas
1 reference
I Krakowski
1 reference
D Larregain-Fournier
1 reference
H Abourachid
1 reference
J M Andrieu
1 reference
C Chastang
1 reference
1 July 1998
1 reference
16
1 reference
7
1 reference
2505-2513
1 reference